Ash American Society Of Hematology 2024. Data to be presented at ash demonstrate that ict01, both at the low and high dose levels, was safe and very well tolerated, and generated high rates of complete remission. Abstracts for the 2024 ash annual meeting and exposition are now available.

Ash to present 2024 honorific awards at annual meeting. Browse the ash events below to find your next hematology meeting.